Skip to content
You are now leaving https://www.ionispharma.com to visit

Ionis’ leadership in RNA-targeted therapeutics recognized at the Oligonucleotide Therapeutics Society annual meeting

– Ionis scientists, including CEO Stanley Crooke, M.D., Ph.D., recognized with prestigious Paper of the Year Award for their work on advancing core antisense research   – Ionis’ Holly Kordasiewicz, Ph.D., executive director of neurological disease drug discovery, to receive distinguished Young